"In a complex business such as biopharmaceutical research, results and products are developed jointly by government, universities, and often incumbents themselves. Each is hesitant to partner with other incumbents due to political, financial, and territorial issues. The only way to overcome and break these barriers was to create a new, multi-sided marketplace that expands across all of these incumbents and integrates their products." - Siamak Baharloo